Antimicrobial resistance is an increasing threat to human populations. The emergence of
multidrug-resistant “superbugs” in mycobacterial infections has further complicated the …

Objectives Interest in phages as adjunctive therapy to treat difficult infections has grown in
the last decade. However, phage dosing and delivery for orthopedic infections have not …

Phage-antibiotic combination treatment is a novel noteworthy drug delivery method in anti-
infection. In the current study, we have isolated a new phage, pB23, against carbapenem …

Phage–antibiotic combination-based protocols are presently under heightened
investigation. This paradigm extends to engagements with bacterial biofilms, necessitating …

Methicillin-resistant Staphylococcus aureus (MRSA) causes biofilm-related medical device
infections. Phage-antibiotic combinations offer potential therapy due to proven in vitro …

Viruses that infect as well as often kill bacteria are called bacteriophages, or phages.
Because of their ability to act bactericidally, phages increasingly are being employed …

We are entering the post-antibiotic era. Antimicrobial resistance (AMR) is a critical problem
in chronic lung infections resulting in progressive respiratory failure and increased mortality …

Phage-antibiotic combinations (PAC) offer a potential solution for treating refractory
daptomycin-nonsusceptible (DNS) methicillin-resistant Staphylococcus aureus (MRSA) …

The persistence of organisms as biofilms and the increase in antimicrobial resistance has
raised the need for alternative strategies. The study objective was to compare the ability of …

The emergence of bacteria resistant to bacteriophage (phage) infection may compromise
the success and effectiveness of phage therapy. The aim of this study was to evaluate the in …